Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Share Price    (AIDL)

Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Revealed: How to Get Rich with Just 3 Stocks

REFRESH
Live BSE Quotes Aug 6, 2020 (Close)
Price (Rs)3,339.15 Open (Rs) 3,399.95 High (Rs) 3,399.95 Low (Rs) 3,310.00
% Change-0.13 Volume 1,907 Value (Rs) 6,356,878 52-Week H/L 3,700.00 / 1,635.30
Live NSE Quotes Aug 6, 2020 (Close)
Price (Rs)3,341.30 Open (Rs) 3,349.85 High (Rs) 3,359.80 Low (Rs) 3,305.00
% Change-0.14 Volume 32,980 Value (Rs) 109,877,862 52-Week H/L 3,670.00 / 1,632.55
Change
1 Day
-0.13%
1 Month
-5.61%
3 Months
2.01%
1 Year
79.84%
5 Years (CAGR)*
22.57%
10 Years (CAGR)*
10.67%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 28.88 P/E Ratio (x) 115.60 Market Cap (Rs m) 83,478.75 P/BV (x) 33.81
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

ASTRAZENECA PHARMA Share Price Today:

ASTRAZENECA PHARMA last traded price was down 0.1% to Rs 3,339.2 on the BSE. On the NSE, ASTRAZENECA PHARMA last traded price was down 0.1% to Rs 3,341.3. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 1.1%. And the benchmark S&P BSE SENSEX was at 38,025.5 (up 1.0%).

Over the last 30 days, the ASTRAZENECA PHARMA share price is down 5.6%. And over the last one year, ASTRAZENECA PHARMA share price is up 79.8%.



What else is happening in the markets today? Dig in...


Today's Market

Sensex Ends 362 Points Higher on RBI Loan Recast; IT and FMCG Stocks Rally(Closing)

Indian share markets ended on a positive note today after the RBI kept the repo rate unchanged at 4%.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets Views On News (Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - MYLAN COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS